Back to search results
Rita Mukhtar
5.0 out of 5 (53)
Rita Mukhtar

Rita Mukhtar, MD

Breast Surgical Oncology | General Surgery

Breast Care Center
1825 Fourth St., Third Floor,
San Francisco, CA 94158
5.0 out of 5 (53)
Virtual visits available
5.0 out of 5 (53)
Virtual visits available
Breast Care Center
1825 Fourth St., Third Floor,
San Francisco, CA 94158

Dr. Rita Mukhtar specializes in breast surgery and general surgery for urgent conditions. For her patients with breast cancer, she offers expertise in total skin-sparing mastectomies, breast conservation, wire localization surgery (used to show the location of tissue requiring biopsy) and sentinel lymph node biopsy (used to see if cancer has spread).

Mukhtar conducts research on breast cancer genetics and risk reduction. She also specifically studies lobular breast cancer (a type that begins in the milk-producing glands) and ductal carcinoma in situ (early breast cancer that has not spread beyond the milk ducts).

While attending medical school at UCSF, Mukhtar received a fellowship from the Doris Duke Charitable Foundation to conduct research on the inflammatory response in sepsis (a life-threatening condition that can develop from infection). She won a resident research award for this work. She remained at UCSF for a residency in general surgery and a research fellowship, funded by the California Breast Cancer Research Program, focusing on the role of inflammatory cells in breast cancer outcomes. She then completed a fellowship in breast cancer surgery while serving as a clinical instructor in general surgery.

  • Board Certifications

    American Board of Surgery, Surgery, 2014

  • Fellowships

    UCSF, General Surgery, 2014

  • Residencies

    UCSF, General Surgery, 2013

  • Internship

    UCSF, General Surgery, 2007

  • Education

    University of California, San Francisco, School of Medicine, 2006

  • Languages

    English

Conditions I specialize in

  • Abnormal mammogram

  • Breast cancer

  • Breast lump

  • Cancer

  • Ductal carcinoma in situ (DCIS)

  • Lobular carcinoma in situ (LCIS)

  • Nipple discharge

Treatments I provide

Where I see patients (1)

    My reviews

    5.0

    Overall Experience
    53 Ratings
    About our process
    Mar 12, 2025
    My doctor has gone out of her way to make sure I was doing ok and carefully and thought explains every step of my treatment.
    Feb 26, 2025
    Dr. Muktar was fantastic. She was prepared, extremely knowledgeable, had detailed answers to all my questions. Completely exceeded my expectations in every way.
    Jan 18, 2025
    Dr.Mukhtar was excellent. Kind, knowledgeable, and spent time answering all questions thoughtfully. She welcomed questions. She did not act like she was in a hurry and did not rush through the appointment, taking time to talk with me and my husband. Her explanations were complete and gave me a good sense of what to expect next. I couldn't ask for a better doctor.
    Jan 10, 2025
    Dr. Mukhtar is excellent. She is a great listener and very careful yet efficient in her responses, explanations, and guidance.
    Jan 04, 2025
    Dr. Mukhtar is WONDERFUL. She is so gracious and kind and easy to understand. I am forever grateful that I was able to be treated by her.
    Nov 13, 2024
    Dr Mukhtar is an excellent doctor - so knowledgeable, explains things well, and is warm and caring.
    Nov 12, 2024
    Dr. Mukhtar was patient, knowledgeable, and instilled confidence that I am getting the best care.
    Mar 27, 2024
    This was the most thorough consult with a physician I have ever received. Dr. Mukhtar reviewed my entire patient history, including all of my imaging records, and summarized them perfectly at the beginning of our call before discussing my questions. She then gave me her expert opinion on my pathology reports so that I could make an informed decision on my treatment next steps. She also made sure to answer all of my questions. Typically, a doctor will spend a max of 20 minutes (and more frequently 5-10 minutes) with a patient. Dr. Mukhtar spent an hour with me, not including the significant time she already spent reviewing my records. It was an amazing consult and I learned so much, and it is evident how much she cares for her patients. It also gave me the confidence to make a key medical decision in a sea of uncertainty. I am so grateful to Dr. Mukhtar and her team.
    Mar 01, 2024
    Dr. Mukhtar gave me a clear explanation of my diagnosis and her surgical intervention.
    Dec 22, 2023
    Dr. Mukhtar is excellent. Very thorough, knowledgeable, caring. She has listened to and addressed my concerns with empathy and patience. I have full confidence in her and would recommend her without hesitation. She is one of the best doctors I've encountered. Some of my other doctors (including at UCFS), while they may be very capable, have been down right rude to me.
    Sep 27, 2023
    Dr. Mukhtar was incredible - so articulate, incisive and informative. So very grateful for her care and expwrtise.
    Aug 02, 2023
    Dr. Mukhtar's response to my diagnosis has been exceptional, and things are moving quickly.
    Jul 28, 2023
    An unbelievable team to help me and my family understand my situation with great understanding, information and care
    Jun 23, 2023
    Dr. Muhktar is a caring and excellent surgeon. I am beyond pleased with her skill and knowledge.
    Jun 03, 2023
    I left empowered and relieved.
    May 26, 2023
    Dr. Mukhtar was so very professional, informative and compassionate. She was also incredibly patient with all of my questions and spent whatever time I needed to feel comfortable with my upcoming procedures. She has a very caring approach.

    Selected research

    See all research
    Decorative Caduceus

    MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpr...

    Create a large scale registry of full genome expression data with clinical data to investigate possible new gene associations with prognostic or predictive value.

    Recruiting

    Decorative Caduceus

    Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

    Feasibility is defined as enrollment of 10-12 patients with metastatic ILC in the first 2 years across all participating sites, and collection of clinical assessments in >=75% of treating medical oncologists

    Recruiting

    Contact me

    Share